| Product NDC: | 60505-3527 |
| Proprietary Name: | Tolterodine Tartrate |
| Non Proprietary Name: | Tolterodine Tartrate |
| Active Ingredient(s): | 1 mg/1 & nbsp; Tolterodine Tartrate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 60505-3527 |
| Labeler Name: | Apotex Corp. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA200164 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120925 |
| Package NDC: | 60505-3527-6 |
| Package Description: | 60 TABLET, FILM COATED in 1 BOTTLE (60505-3527-6) |
| NDC Code | 60505-3527-6 |
| Proprietary Name | Tolterodine Tartrate |
| Package Description | 60 TABLET, FILM COATED in 1 BOTTLE (60505-3527-6) |
| Product NDC | 60505-3527 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Tolterodine Tartrate |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20120925 |
| Marketing Category Name | ANDA |
| Labeler Name | Apotex Corp. |
| Substance Name | TOLTERODINE TARTRATE |
| Strength Number | 1 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] |